Robotic surgery of head and neck cancers, a narrative review
https://doi.org/10.4081/ejtm.2020.8727
Accepted: 29 December 2019
HTML: 55
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Head and neck cancers are the most common cancers in the body. Treatments are determined on the basis of the location and stage of the primary tumor. The goal of treatment is to eliminate the tumor, prevent recurrence or metastasis, and maintain the quality of life. There are several treatments available for the management of head and neck cancers, including surgery, radiation therapy, chemotherapy, new molecular agents, and a combination of them. Transoral robotic technique is a short-time operation using a type of robotic machine in which the patient undergoes anesthesia for a shorter time and the side effects of this operation and the time of hospitalization are less than open surgery. Due to the importance of speed and accuracy in head and neck cancer surgery and the importance of application of robotics in surgery, the present study was designed and implemented to review the application of robotics in the management of head and neck cancers. In this review study, the keywords: application, robotic, surgical, head cancer, transoral robotic surgery (TORS), and neck cancer, were searched in ISI, PubMed, Scopus, Google scholar databases. Related articles written domestically or abroad that have covered areas such as the background of transoral robotic surgery, maintaining organ function and approaches, the advantages and disadvantages of TORS, the affordability of TORS, the combination of TORS with other therapeutic approaches published from 2003 to 2019 were reviewed. The use of robotic surgery for precise operations such as head and neck cancers seems to be essential. More advanced robotic devices are expected to expand the surgery treatment for head and neck cancers as well as the results of using TORS for oncologic optimization and acceptability of results while maintaining organ function and patient's quality of life.
Hay A, Nixon IJ. Recent advances in the understanding and management of oropharyngeal cancer. F1000Res. 2018;7: pii: F1000 Faculty Rev-1362. DOI: https://doi.org/10.12688/f1000research.14604.1
Baskin RM, Boyce BJ, Amdur R, et al. Transoral robotic surgery for oropharyngeal cancer : patient selection and special considerations. Cancer Manag Res. 2018; 10:839–46. DOI: https://doi.org/10.2147/CMAR.S118891
Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPVassociated oropharyngeal cancer. Oral Oncol. 2014;50:380–6. DOI: https://doi.org/10.1016/j.oraloncology.2013.12.019
Mirghani H, Blanchard P. Treatment de-escalation for HPV-driven oropharyngeal cancer: where do we stand? ClinTranslRadiatOncol. 2018;8:4–11. DOI: https://doi.org/10.1016/j.ctro.2017.10.005
Arora A, Kotecha J, Acharya A, et al. Determination of biometric measures to evaluate patient suitability for transoral robotic surgery. Head Neck. 2015; 37:1254–60. DOI: https://doi.org/10.1002/hed.23739
Gorphe P. A contemporary review of evidence for transoral robotic surgery in laryngeal cancer. Front Oncol. 2018; 8:121. DOI: https://doi.org/10.3389/fonc.2018.00121
de Almeida JR, Byrd JK, Wu R, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014; 124:2096–102. DOI: https://doi.org/10.1002/lary.24712
Kelly K, Johnson-Obaseki S, Lumingu J, et al. Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review. Oral Oncol. 2014;50:696–703. DOI: https://doi.org/10.1016/j.oraloncology.2014.04.005
Ward MC, Koyfman SA. Transoral robotic surgery: the radiation oncologist’s perspective. Oral Oncol. 2016; 60:96–102. DOI: https://doi.org/10.1016/j.oraloncology.2016.07.008
Moore EJ, Abel KM Van, Price DL, et al. Transoral robotic surgery for oropharyngeal carcinoma : surgical marginsand oncologic outcomes. Head Neck. 2018;40, 1–9.
Gleysteen J, Troob S, Light T, et al. The impact of prophylactic external carotid artery ligation on postoperative bleeding after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. Oral Oncol. 2017;70:1–6.
Holsinger FC, Ferris RL. Transoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers, and clinical trials. J ClinOncol Off J Am SocClinOncol. 2015;33:3285–92.
Rich JT, Milov S, Lewis JS Jr, et al. Transoral laser microsurgery (TLM) +/− adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope. 2009; 119:1709–19. DOI: https://doi.org/10.1002/lary.20552
Haughey BH, Hinni ML, Salassa JR, et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011; 33:1683–94. DOI: https://doi.org/10.1002/hed.21669
Haus BM, Kambham N, Le D, et al. Surgical robotic applications in otolaryngology. Laryngoscope. 2003; 113:1139–44. DOI: https://doi.org/10.1097/00005537-200307000-00008
Weinstein GS, O’Malley BW Jr, Hockstein NG. Transoral robotic surgery: supraglottic laryngectomy in a canine model. Laryngoscope. 2005; 115:1315–9. DOI: https://doi.org/10.1097/01.MLG.0000170848.76045.47
O’Malley BW Jr, Weinstein GS, Snyder W, et al. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope. 2006; 116:1465–72. DOI: https://doi.org/10.1097/01.mlg.0000227184.90514.1a
Weinstein GS, O’Malley BW Jr, Snyder W, et al. Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol. 2007; 116:19–23. DOI: https://doi.org/10.1177/000348940711600104
Weinstein GS, O’Malley BW Jr, Snyder W, et al. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg. 2007; 133:1220–6. DOI: https://doi.org/10.1001/archotol.133.12.1220
Weinstein GS, O’Malley BW Jr, Magnuson JS, et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope. 2012; 122:1701–7. DOI: https://doi.org/10.1002/lary.23294
Zevallos JP, Mitra N, Swisher-McClure S. Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma. Head Neck. 2016; 38:402–9. DOI: https://doi.org/10.1002/hed.23909
Dowthwaite SA, Franklin JH, Palma DA, et al. The role of transoral robotic surgery in the management oforopharyngeal cancer: a review of the literature. ISRN Oncol. 2012;2012:1–14. DOI: https://doi.org/10.5402/2012/945162
Chia SH, Gross ND, Richmon JD. Surgeon Experience and Complicationswith Transoral Robotic Surgery (TORS). Otolaryngol Neck Surg. 2013;149:885–92. DOI: https://doi.org/10.1177/0194599813503446
Yeh DH, Tam S, Fung K, et al. Transoralrobotic surgery vs. radiotherapy for management of oropharyngeal squamouscell carcinoma—A systematic review of the literature. Eur J SurgOncol. 2015;41:1603–14. DOI: https://doi.org/10.1016/j.ejso.2015.09.007
Rodrigo JP, Coca-Pelaz A, Suárez C. The current role of partial surgeryas a strategy for functional preservation in laryngeal carcinoma. ActaOtorrinolaringol. 2011;62:231–8.
Hockstein NG, O’Malley BW, Weinstein GS. Assessment of intraoperativesafety in transoral robotic surgery. Laryngoscope. 2006; 116:165–8. DOI: https://doi.org/10.1097/01.mlg.0000199899.00479.75
Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgeryfor oropharyngeal squamous cell carcinoma: a prospective study offeasibility and functional outcomes. Laryngoscope. (2009) 119:2156–64. DOI: https://doi.org/10.1002/lary.20647
Zenga J, Suko J, Kallogjeri D, et al.Postoperative hemorrhage and hospital revisit after transoral robotic surgery.Laryngoscope. 2017;127:2287–92 DOI: https://doi.org/10.1002/lary.26626
Mandal R, Duvvuri U, Ferris RL, et al. Analysis of post-transoral robotic-assisted surgery hemorrhage:frequency, outcomes, and prevention. Head Neck. 2015;38:E776–82. DOI: https://doi.org/10.1002/hed.24101
Gleysteen J, Troob S, Light T, et al. The impact of prophylactic external carotid artery ligationon postoperative bleeding after transoral robotic surgery (TORS) fororopharyngeal squamous cell carcinoma. Oral Oncol. 2017;70:1–6. DOI: https://doi.org/10.1016/j.oraloncology.2017.04.014
Park YM, Keum KC, Kim HR, et al. A clinicaltrial of combination neoadjuvant chemotherapy and transoral robotic surgeryin patients with T3 and T4 laryngo-hypopharyngeal cancer. Ann SurgOncol.2018;25:864–71.
Chan JYK, Wong EWY, Tsang RK, et al. Early results of a safety and feasibility clinical trial of a novel singleportflexible robot for transoral robotic surgery. Eur Arch Oto-Rhino-Laryngol.2017;274:3993–6. DOI: https://doi.org/10.1007/s00405-017-4729-y
Weinstein GS, O’Malley BW, Snyder W, et al. Transoral roboticsurgery: supraglottic partial laryngectomy. Ann OtolRhinolLaryngol. 2007;116:19–23.
Ozer E, Alvarez B, Kakarala K, et al. Clinicaloutcomes of transoral robotic supraglottic laryngectomy. Head Neck. 2012;1158–61. DOI: https://doi.org/10.1002/hed.23101
Mendelsohn AH, RemacleM, Van Der Vorst S, et al. Outcomesfollowing transoral robotic surgery: supraglottic laryngectomy. Laryngoscope.2012; 123:208–14. DOI: https://doi.org/10.1002/lary.23621
Razafindranaly V, Lallemant B, Aubry K, et al. Clinical outcomes with transoral robotic surgery forsupraglottic squamous cell carcinoma: experience of a French evaluationcooperative subgroup of GETTEC. Head Neck. 2016; 38:E1097–101. DOI: https://doi.org/10.1002/hed.24163
de Almeida JR, Li R, Magnuson JS, et al. Oncologic outcomes after transoral robotic surgery. JAMA Otolaryngol NeckSurg. 2015; 141:1043. DOI: https://doi.org/10.1001/jamaoto.2015.1508
Yee S. Transoral robotic surgery. AORN J. 2017; 105:73–84. DOI: https://doi.org/10.1016/j.aorn.2016.11.011
Tae K, Ji YB, Song CM, et al. Robotic selective neckdissection by a postauricular facelift approach. Otolaryngol Neck Surg. 2013; 150:394–400. DOI: https://doi.org/10.1177/0194599813515431
Kim MJ, Lee J, Lee SG, et al. Transaxillaryrobotic modified radical neck dissection: a 5-year assessment ofoperative and oncologic outcomes. SurgEndosc. 2016; 31:1599–606.
Byeon HK, Holsinger FC, Kim DH, et al. Feasibility of robot-assisted neck dissection followed bytransoral robotic surgery. Br J Oral Maxillofac Surg. 2015;53:68–73. DOI: https://doi.org/10.1016/j.bjoms.2014.09.024
Hammoudi K, Pinlong E, Kim S, et al. Transoralrobotic surgery versus conventional surgery in treatment for squamous cellcarcinoma of the upper aerodigestive tract. Head Neck. 2015;37:1304–9. DOI: https://doi.org/10.1002/hed.23752
Voutyrakou DA, Papanastasis A, Chatsikian M, Katrakazas P, Koutsouris D.The Journal of Engineering JoE ; IET Open Access Research. IET Digital Library(2017). Available online at: https://digital-library.theiet.org/content/journals/ 10.1049/joe.2017.0409 (Accessed February 13, 2019).
Hay A, Migliacci J, KarassawaZanoni D, et al. Complications following transoral robotic surgery (TORS): adetailed institutional review of complications. Oral Oncol. 2017;67:160–6. DOI: https://doi.org/10.1016/j.oraloncology.2017.02.022
Aubry K, Vergez S, de Mones E, et al. Morbidity and mortality revue of the French group of transoral robotic surgery: a multicentric study. J Robot Surg. 2016;10:63–7. DOI: https://doi.org/10.1007/s11701-015-0542-z
Maxwell JH, Rath TJ, Byrd JK, et al. Accuracy of computed tomography to predict extracapsular spread in p16-positive squamous cell carcinoma. Laryngoscope. 2015; 125:1613–8. DOI: https://doi.org/10.1002/lary.25140
Dombrée M, Crott R, Lawson G, et al. Costcomparison of open approach, transoral laser microsurgery and transoralrobotic surgery for partial and total laryngectomies. Eur Arch Oto-Rhino-Laryngol. 2014; 271:2825–34. DOI: https://doi.org/10.1007/s00405-014-3056-9
Rudmik L, An W, Livingstone D, et al.Making a case for high-volume robotic surgery centers: a cost-effectivenessanalysis of transoral robotic surgery. J SurgOncol. 2015; 112:155–63. DOI: https://doi.org/10.1002/jso.23974
Verma V, Allen PK, Simone CB, et al. Association of treatment athigh-volume facilities with survival in patients receiving chemoradiotherapy for nasopharyngeal cancer. JAMA Otolaryngol Neck Surg. 2017; 144:86–9.
Amato L, Fusco D, Acampora A, et al. Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data. Epidemiol Prev. 2017; 41:1–128.
Eskander A, Merdad M, Irish JC, et al. Volume-outcome associations in head and neck cancer treatment: a systematic review and meta-analysis. Head Neck. 2014; 36:1820–34. DOI: https://doi.org/10.1002/hed.23498
Schoppy DW, Rhoads KF, Ma Y, et al. Measuring institutional quality in head and neck surgery using hospital-level data. JAMA Otolaryngol Neck Surg. 2017; 143:1111. DOI: https://doi.org/10.1001/jamaoto.2017.1694
Morche J, Mathes T, Pieper D. Relationship between surgeon volume and outcomes: a systematic review of systematic reviews. Syst Rev. 2016; 5:204. DOI: https://doi.org/10.1186/s13643-016-0376-4
Mäkitie AA, Keski-Säntti H, Markkanen-Leppänen M, et al. Transoral robotic surgery in the Nordic countries: current status and perspectives. Front Oncol. 2018: 8:289. DOI: https://doi.org/10.3389/fonc.2018.00289
Garas G, Arora A. Robotic head and neck surgery: history, technical evolution and the future. Orl. 2018;80:1–8. DOI: https://doi.org/10.1159/000489464
Owadally W, Hurt C, Timmins H, et al. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015;15:602. DOI: https://doi.org/10.1186/s12885-015-1598-x
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
